On Tuesday, Perspective Therapeutics Inc (AMEX: CATX) was 5.00% up from the session before settling in for the closing price of $2.4. A 52-week range for CATX has been $1.60 – $5.39.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -9.86%. When this article was written, the company’s average yearly earnings per share was at 0.32%. With a float of $61.64 million, this company’s outstanding shares have now reached $74.34 million.
Perspective Therapeutics Inc (CATX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Perspective Therapeutics Inc stocks. The insider ownership of Perspective Therapeutics Inc is 17.09%, while institutional ownership is 63.28%. The most recent insider transaction that took place on Nov 13 ’25, was worth 22,295. In this transaction Chief Accounting Officer of this company bought 11,000 shares at a rate of $2.03, taking the stock ownership to the 59,800 shares. Before that another transaction happened on Nov 12 ’25, when Company’s Director bought 9,498 for $2.10, making the entire transaction worth $19,946. This insider now owns 9,864 shares in total.
Perspective Therapeutics Inc (CATX) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.24 earnings per share (EPS) during the time that was better than consensus figure (set at -0.25) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.32% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.62% during the next five years compared to -9.86% drop over the previous five years of trading.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
You can see what Perspective Therapeutics Inc (CATX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 175.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.33 in one year’s time.
Technical Analysis of Perspective Therapeutics Inc (CATX)
The latest stats from [Perspective Therapeutics Inc, CATX] show that its last 5-days average volume of 1.59 million was superior to 1.09 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 86.70%.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 16.46%, which indicates a significant decrease from 89.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.19 in the past 14 days, which was lower than the 0.26 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.90, while its 200-day Moving Average is $3.01. Now, the first resistance to watch is $2.61. This is followed by the second major resistance level at $2.69. The third major resistance level sits at $2.79. If the price goes on to break the first support level at $2.42, it is likely to go to the next support level at $2.31. The third support level lies at $2.23 if the price breaches the second support level.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
There are 74,338K outstanding shares of the company, which has a market capitalization of 187.33 million. As of now, sales total 1,450 K while income totals -79,280 K. Its latest quarter income was 210 K while its last quarter net income were -25,970 K.
